Immune system stimulation via presentation of conserved regions of the human immunodeficiency virus proteome

This target refers to a vaccine or immunotherapeutic strategy that aims to stimulate the immune system—particularly T-cell responses—by presenting highly conserved regions of the HIV proteome. The rationale is that these conserved regions are less variable across different HIV strains, making them ideal targets for broad and effective immune responses. Examples of conserved regions targeted are within Gag, Env (gp41) and Nef proteins. The goal is to elicit robust CD4+ and CD8+ T cell responses specifically toward epitopes less likely to mutate under immune pressure, thereby minimizing viral escape. Early clinical trials have demonstrated safety and promising immunogenicity.

Other names

HIV Conserved Region VaccineCRVHIVconsvConserved element HIV vaccine

Elicits T-cell responses (CD4+ and CD8+) against conserved HIV epitopes to induce cellular immunity and viral lysis.